Medidata Solutions (Nasdaq: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced its plans for the 46^th Annual Meeting of the Drug Information Association (DIA), taking place June 13-17 in Washington, D.C. Medidata will spotlight several major new product releases; company leaders will speak on the latest trends in clinical development; and Medidata will also co-host a booth tour to showcase interoperability between two clinical technologies.

Medidata will highlight several new product offerings at its Booth #1517, providing demos of the latest version of its Medidata Rave^® platform with new modules such as Rave Safety Gateway and Rave Monitor, which broaden already extensive capabilities in capture, management and reporting of clinical, operational and safety data for clinical trials; a new, web-based version of trial planning product, Medidata Grants Manager^®; and other products including Medidata CRO Contractor^® and Medidata Designer^®.

Booth Tour

SAS^® and Medidata are co-hosting a booth tour to showcase web services-based interoperability between Medidata Rave and the SAS Drug Development clinical data repository and analysis system using CDISC operational data model (ODM) standards. Participants will be able to view real-time data exchange between the Medidata Rave system and SAS Drug Development, a joint solution designed to help reduce cost through on-demand data access and accelerate analysis and decision making. To see the benefits of this solution, please visit SAS at booth #1601 and Medidata at booth #1517.

Medidata Speaker Sessions

Focusing on emerging issues in today’s clinical research environment, members of Medidata’s management team will participate in a variety of sessions at this year’s annual DIA meeting, including:

Cracking the Globalization Code: How to Do It Smarter, Faster, Better - While Still Conforming to Evolving Regulatory Framework
Speaker: Sondra Pepe, Senior Client Relations Specialist
Date & Time: Monday, June 14, 1:30 p.m.
Room: 152B

Standards-based Approach to Creating One Elegant Multi-system Solution
Speaker: Andrew Newbigging, Vice President, Integrations Development
Date & Time: Monday, June 14, 3:30 p.m.
Room: 204BC

Electronic Data Capture and Clinical Outsourcing: Structuring Partnerships for Best Results
Speaker: Graham Bunn, Vice President, Partnerships and Alliances
Date & Time: Monday, June 14, 3:30 p.m.
Room: 151A

Using Agile Practices on Validated Solutions
Speaker: Andrew Newbigging, Vice President, Integrations Development
Date & Time: Tuesday, June 15, 4:00 p.m.
Room: 209AB

Electronic Data Capture in Phase 1 - Do the Pros Outweigh the Cons?
Speaker: Anne Zielinski, Vice President, Alliances
Date & Time: Wednesday, June 16, 8:30 a.m.
Room: 206

How to Select a Cloud Computing Provider
Speaker: Glenn D. Watt, Vice President, Information Security and Privacy
Date & Time: Wednesday, June 16, 8:30 a.m.
Room: 209AB

An International Perspective on the Use of Computerized Systems
Speaker: Patricia Beers Block, Vice President, Strategic Regulatory Initiatives
Date & Time: Thursday, June 17, 8:30 a.m.
Room 154AB

About Medidata Solutions Worldwide

Medidata Solutions (www.mdsol.com) is a leading global provider of SaaS-based clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer^®), investigator benchmarking and budgeting (Medidata Grants Manager^®), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor^®), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave^®). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.